{"version": "1.2.0", "chapters": [{"title": "Why innovation systems matter in MedTech", "startTime": 0}, {"title": "Introducing in-studio guest, Chris Dawson, TTP", "startTime": 1}, {"title": "What innovation looks like inside multidisciplinary teams", "startTime": 2}, {"title": "Start of keynote interview with Rebecca Gottlieb, Biolinq", "startTime": 3}, {"title": "From startup to Medtronic: scaling innovation across environments", "startTime": 4}, {"title": "Internal venture programs: designing systems for ideas to surface", "startTime": 5}, {"title": "Leadership as barrier removal, not control", "startTime": 6}, {"title": "Why Rebecca chose Biolinq: platforms, microneedles, and possibility", "startTime": 7}, {"title": "Rethinking glucose monitoring for Type 2 diabetes", "startTime": 8}, {"title": "FDA De Novo clearance and sustaining teams through long timelines", "startTime": 9}, {"title": "The future of biosensing: DNA-based receptors and new analytes", "startTime": 10}, {"title": "Leadership reflections and closing: curiosity as an innovation engine", "startTime": 11}]}